Drug Profile
Malaria DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics
Alternative Names: Malaria DNA vaccine VCL-2510; MuStDO 5; VCL-2510Latest Information Update: 14 Sep 2022
Price :
$50
*
At a glance
- Originator Naval Medical Research Center
- Class Antimalarials; DNA vaccines; Gene therapies; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 15 Sep 2015 No recent reports on development identified - Phase-I/II for Malaria (Prevention, volunteers) in USA (IM)